Questions remain about whether the renal effects of ACE inhibitors and ARBs are equivalent, whether a combination of the two classes are more effective than either one alone, and whether either ...

Routine use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is recommended in proteinuric nontransplant kidney disease patients, to reduce proteinuria and ...

To test the hypothesis that an angiotensin-receptor blocker (ARB), either alone or combined with an ACE inhibitor ... it was found to be equivalent to captopril for reducing all-cause mortality.

Inhibition of the renin–angiotensin system using either an angiotensin-converting-enzyme (ACE) inhibitor or an angiotensin-receptor blocker (ARB) effectively decreases rates of urinary protein ...